A Case of Shwachman-Diamond Syndrome Confirmed with Genetic Analysis in a Korean Child by Lee, Jeong Hee et al.
INTRODUCTION
Shwachman-Diamond syndrome (SDS; congenital pancre-
atic hypoplasia with hematological abnormalities; OMIM
260400) is an autosomal recessive disease with characteris-
tics of exocrine pancreatic insufficiency, due to fatty infiltra-
tion and atrophy, short stature, and chronic neutropenia (1-
3). After cystic fibrosis, SDS is the most common inherited
cause of exocrine pancreatic dysfunction in the Western world.
However, it has rarely been reported in Asia; only two cases
of SDS have been reported in Korea: a child who died of
hematological malignancy (4) and another case of a 21-yr-old
woman who underwent allogeneic bone marrow transplan-
tation (5).
The SDS phenotype is extremely heterogeneous, and spe-
cific features of this disease change with advancing age. Diag-
nosis is made primarily based on clinical symptoms, and for
diagnostic confirmation, genetic analysis may be performed. 
The recently discovered, causative gene for this disorder,
Shwachman-Bodian-Diamond syndrome (SBDS) gene is
located at chromosome 7q11 and contains five exons. A pseu-
do gene (SBDSP) has also been identified with a locally dupli-
cated 305 kb genomic segment and 97% nucleotide identi-
ty with the disease-causing gene (6). Genetic analysis in West-
ern patients has identified two common mutations: c.258+
2T>C (p.84Cfs3), and c.183_184TA>CT (p.K62X), result-
ing from conversion of exon 2 segments (6). 
We report a child with diverse clinical manifestations of
SDS including short stature, steatorrhea, dental caries, skele-
tal system abnormalities, and neutropenia; the clinical diag-
nosis was confirmed by genetic analysis for the first time in
Korea.
CASE REPORT
A 42-month-old girl was admitted to Konkuk university
hospital because of steatorrhea and short stature. The patient
was born at 36 weeks and four days of gestation with a birth
weight of 2.5 kg (25-50 percentile) and height of 51 cm (90
percentile). There were no problems during the perinatal
period; early growth and development were normal. How-
ever, at the age of about three months, she presented to the
hospital with convulsion and neutropenia. Since then she has
had frequent prulent otitis media and pneumonias. After
teething, dental caries developed early; she required frequent
dental treatment. During late infancy, steatorrhea with foul
odor developed; the amount of stool was large for age. The
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A Case of Shwachman-Diamond Syndrome Confirmed with Genetic
Analysis in a Korean Child
Shwachman-Diamond syndrome (SDS) is an autosomal recessive genetic disor-
der, consisting of exocrine pancreatic insufficiency, chronic neutropenia, neutrophil
chemotaxis defects, metaphyseal dysostosis, short stature, dental caries, and mul-
tiple organ involvements. Although SDS is the second most common hereditary
abnormality of exocrine pancreas following cystic fibrosis in the Western countries,
it has rarely been reported in Asia. We diagnosed a case of SDS in a 42-month-old
girl, and genetic analysis including the relatives of the patient confirmed the diag-
nosis for the first time in Korea. She had short stature, steatorrhea, dental caries,
and recurrent prulent otitis media and pneumonias. Laboratory studies revealed
cyclic neutropenia, and serum levels of trypsin, amylase, and lipase were decreas-
ed. Simple radiography revealed metaphyseal sclerotic changes at the distal femur.
A CT scan demonstrated a fatty infiltration and atrophy of the pancreas. On direct
sequencing analysis of Shwachman-Bodian-Diamond Syndrome gene exon 2
region, the patient was homozygous for the c.258+2T>C mutation and heterozy-
gous for the c.183_184TA>CT mutation and c.201A>G single nucleotide polymor-
phism. Treatment with pancreatic enzyme replacement, multivitamin supplemen-
tation, and regular to high fat diet improved her weight gain and steatorrhea.
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patient had performed normal, active physical and cognitive
activities for age. The family history was negative for simi-
lar clinical problems. 
Her height was 87.7 cm (less than third percentile), weight
was 11.5 kg (less than third percentile), head circumference
was 48 cm (50th percentile), and the body proportions were
appropriate. The vital signs were normal for age. She had
angular stomatitis, and examination of the teeth revealed
many dental caries and crown prostheses. The liver and spleen
were not palpated. Examination of the musculoskeletal sys-
tem and neurological examinations were all normal. 
The results of the laboratory studies were as follows: hemo-
globin 11.3 g/dL, leukocytes 3,000/ L (neutrophils 17.3%,
lymphocytes 59.5%, monocytes 22.9%, basophils 0.3%, and
eosinophils 0%), platelets 152 K/ L, serum amylase less than
30 U/dL, serum lipase 15 U/L, serum trypsin 38 ng/mL,
glucose 88 mg/dL, aspartate aminotransferase (AST) 61 IU/
L, alanine aminotransferase (ALT) 40 IU/L, prothrombine
time (PT) 78% (INR 1.19), and activated partial thrombo-
plastin time (aPTT) 48.3 sec. Serum calcium, phosphate,
total protein, and albumine levels and urinalysis were nor-
mal; the size of fat in stool was increased (170  m). On radi-
ological examination, the bone age was 27 months; trans-
verse sclerotic changes were detected at the metaphysis of
distal femurs. On the abdominal CT scan, marked fatty infil-
tration of the pancreas was detected (Fig. 1). A small bowel
series revealed no abnormality. 
Genetic analysis of the patient and her relatives was per-
formed. The sequence of the primer for Sbds2D1 was AAAT-
GGTAAGGCAAATACGG and primer for Sbds2R was AC-
CAAG TTCTTTATTATTAGAAGTGAC (7). The geno-
type of the patient was homozygous for the c.258+2T>C
mutation and heterozygous for the c.183_184TA>CT muta-
tion and c.201A>G single nucleotide polymorphism (SNP);
her father and paternal grandmother were heterozygous for
the c.183_184TA>CT; 258+2T>C mutations, and c.201A>
G SNP, and her mother was heterozygous for the c.258+2T>C
mutation. The patient’s younger twin brothers, grandfather,
and paternal aunt revealed wild-type sequence in exon 2 region
of the SBDS gene (Fig. 2, 3). 
Initially, the patient was treated with parenteral nutrition,
with pancreatic enzyme replacement (Beasae
�, Daewoong
pham., Seoul, Korea, 1 tablet: higher than 20,000 USP unit
amylase, higher than 25,000 USP unit protease, 15,000 IU)
based on the amount of lipase required for age, and with mul-
tivitamins (Alvityl syrup
�, Youngjin phama., Seoul, Korea),
while providing normal to high-fat diet. The amount of feces
decreased, the consistency became harder, and malodor also
decreased. The size of fat in stool decreased. The patient’s
weight increased to 12.7 kg, and she was discharged from
the hospital. In the outpatient clinic, vaccination for pneu-
mococcus was performed, and recently, powdered pancre-
lipase (Viokase
�, Axcan pharm., Montreal, Canada; lipase
16,800 USP/0.8 gm) was obtained from Canada; she is tak-
ing 0.25-0.3 gm (5,000 USP) per meal with a regular diet
and multivitamin supplement, and her bowel movements
Fig. 1. CT scanning shows low-attenuated pancreas, suggesting
fatty infiltration.
Fig. 2. Mutations in SBDS causing SDS. (A) Map of SBDS (coding
regions in light blue, non-coding regions in dark blue) and sequence
alignment of the exon 2 region of SBDS and SBDSP, with genetic-
specific (green) and pseudogene-specific (red) sequences indi-
cated. The sequence differences in SBDSP present at position
141, 183, 201, 258+2, 258+124, and 258+126. (B) Electrophero-
gram for direct sequencing from the exon 2 region of SBDS show-
ed sequence changes (arrow) in proband with SDS that was deriv-
ed from gene mutation (c.258+2T>C homozygous mutation). (C)
On direct sequencing analysis of SBDS exon 2 region of the the
patient’s relatives revealed c.183_184TA>CT mutation and c.201A>
G single nucleotide polymorphism (SNP) in addition to c.258+2T>C
mutation. 
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further improved with this treatment.
DISCUSSION
SDS was described by Bodian et al. for the first time in
1964 (1); however, the report by Shwachman et al. on five
cases in pediatric patients with severe pancreatic exocrine
insufficiency and bone marrow dysfunction was the first sys-
tematic report (2). 
The clinical course of SDS is diverse. Common findings
include exocrine pancreatic insufficiency, short stature, meta-
physeal chondrodysplasia, hematological abnormalities, fre-
quent infection, dental caries, mental retardation, pontine
leukoencephalopathy, decreased muscle tone, hepatomegaly
and elevated serum aminotransferases, renal tubular dysfunc-
tion, ichthyosis in the skin, delayed puberty, diabetes melli-
tus, myocardial fibrosis, and Hirschsprung’s disease. 
The essential elements needed to consider the diagnosis
are exocrine pancreatic insufficiency and bone marrow dys-
function; short stature, skeletal abnormalities, hepatomegaly,
elevation of aminotransferase are used to provide supportive
evidence of the diagnosis of SDS. Genetic analysis may be
used to confirm the diagnosis, or for prenatal diagnosis or pre-
symptomatic diagnosis within a family as in this case. 
Management of a patient with SDS should be multidisci-
plinary; specialties involved in patient care include pediatric
gastroenterologist, hematologist, dentist, dietician, and psy-
chologist. Because a significant percentage of patients suffer
from skeletal, dental, and hematological disorders, anticipa-
tory monitoring is advocated. For gastrointestinal manifes-
tations, the mainstay of treatment is pancreatic enzyme ther-
apy, medium-chain triglyceride, and fat-soluble vitamin sup-
plements, together with a normal to increased fat diet. With
this treatment, steatorrhea resolves and body weight increas-
es; however, growth is not generally accelerated (3).
An increased risk for developing myelodysplastic syndrome
(MDS) and acute myeloid leukemia (AML) are the main
hematological manifestations (8). The detection of various
acquired cytogenetic abnormalities in the bone marrow are
markers for a clonal evaluation and often heralds transforma-
tion to a more severe form of MDS and/or AML (9). Hence,
regular hematological surveillance is required. For the treat-
ment of hematological abnormalities in SDS, stem cell trans-
plantation has been attempted (10); bone marrow transplan-
tation for hematological malignancies in SDS has also been
reported (5, 11). However, SDS patients may be more sus-
ceptible to transplant-related complications than other trans-
plant patients.
SDS inherits as an autosomal recessive trait (3). The SBDS
gene is located on chromosome 7q11. The SBDS gene is com-
posed of 5 exons; it has a 1.6-kb transcript and encode a pro-
tein of 250 amino acids, which is a member of highly con-
served protein family. Its pseudogene (SBDSP), which has a
90% genetic homology with the SBDS gene, is located in the
vicinity and contains critical deletions and nucleotide changes
that would render the hypothetical encoded nonfunctional
protein. 
Genetic analysis in Caucasion patients has revealed two com-
mon mutations associated with SDS, those resulting from
gene conversion due to recombination between the SBDS
and SBDSP genes. The c.258+2T>C mutation results in pre-
mature protein truncation due to a change in the splice site
(p.84Cfs3) at the second exon; this is the most frequent muta-
tion (6). In this study, genetic analysis of the patient and rel-
atives revealed the c.258+2T>C mutation; the patient was a
homozygote for the c.258+2T>C mutations. The patient’s
father, paternal grandmother, and the patient’s mother were
heterozygous for the c.258+2T>C mutation. In addition to
the c.258+2T>C mutation, the c.183_184TA>CT mutation
Fig. 3. The pedigree of the family is shown with the proband affect-
ed with SDS indicated by black symbol. On direct sequencing
analysis of SBDS exon 2 region, the proband were shown to be
homozygous for the c.258+2T>C mutation and heterozygous for
the c.183_184TA> CT mutation and c.201A>G single nucleotide
polymorphism (SNP). Her father and paternal grandmother were
heterozygous for the c.183_184TA>CT; 258+2T>C mutations
and c.201A>G SNP. Her mother was heterozygous for the c.258+
2T>C mutation. Her twin brothers, grandfather, and paternal aunt
had no mutations in the exon 2 region of the SBDS gene.
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Nt, nucleotide.
?
?
?
Dead male
C
T
A
A
T
Nt.
141
183
184
201
258
C
T
A
A
T
C
C
T
G
C
C
T
A
A
T
C
T
A
A
T
Nt.
141
183
184
201
258
C
T
A
A
T
C
C
T
G
C
Nt.
141
183
184
201
258
C
T
A
A
C
C
T
A
A
T
C
T
A
A
T
C
T
A
A
T
C
T
A
A
T
C
C
T
G
C
C
T
A
A
T
C
T
A
A
T
C
T
A
A
C
Carrier female
Status uncertain
Carrier male Patient
?
?Shwachman-Diamond Syndrome 145
that results in in-frame stop codon (p.K62X) at position 62
was the second common mutation in a Western study (6).
In our case, the patient’s father and paternal grandmother
were also heterozygous for the c.183_184TA>CT mutation.
This result suggests that the c.183_184TA>CT mutation
may also be responsible for SDS in Korea. A recent study
from Japan also revealed that the c.258+2T>C mutation
and the c.183_184TA>CT mutation were common (12).
Therefore, the c.258+2T>C mutation and the c.183_184TA>
CT mutation may be the important mutations underlying
SDS in Asians, similar to Western reports. The c.201A>G
SNP found in the patient’s father and paternal grandmother
was turned out to be silent polymorphism (6). 
With respect to haplotype, the proband had [c.183_184-
TA>CT; c.201A>G; c.258+2T>C] with wild genomic DNA
sequence at 141, and this haplotype was found in one chromo-
some out of seven patients with SDS in Japan (13). [c.141C>
T; c.183_184TA>CT; c.201A>G; c.258+ 2T>C] haplotype
was found in two chromosomes out of 15 patients with SDS
in Italy (7) and in one chromosome out of seven patients in
Japan (13). 
A recent Italian study revealed novel mutations for SDS,
not resulting from gene conversion events, but rather a mis-
sense mutation, nonsense mutation, and frame-shift muta-
tion (7).
The identification of mutations makes it possible for defi-
nite diagnosis in presymptomatic patients, including siblings
of the proband as in the case reported here, as well as confirma-
tion of the diagnosis when the clinical manifestations are not
conclusive. In addition, this information provides the basic
knowledge for recurrence risk assessment and genetic coun-
seling for affected families. The relationship between geno-
type and phenotype has not been established in SDS, yet. Two
Italian patients had [c.141C>T; c.183_184TA>CT; c.201A>
G; c.258+2T>C]+[c.258+2T>C] genotype; one with ane-
mia, neutropenia, thrombocytopenia, pancreatic insufficien-
cy, metaphyseal dyschondroplasia of the femoral head, narrow
chest, and genu valgum, while the other had neutropenia,
pancreatic insufficiency, and metaphyseal dyschondroplasia of
the femoral head (7). The patient of the present report had a
similar genotype except with wild genomic DNA sequence
at 141, but she had cyclic neutropenia and pancreatic insuf-
ficiency without definite skeletal abnormalities, yet. 
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